There is an increased focus on the importance of preserving the brain in the MS community. Early initiation of treatments that control the inflammatory process and reduce the overall rate of brain volume loss is at the core of these discussions. In his
talk Prof Alex Rovira will talk about the clinical impact of brain atrophy in MS and how global brain volume loss is associated with and predicts disability in all clinical MS phenotypes. An association between treatment effects on brain volume and disability has been demonstrated in clinical trials.
Listen in and have the opportunity to ask questions and have peer-to-peer exchange with a top international MS expert!